Besides, freshly derived cells from pediatric GBM tumours and orthotropic xenografts generated from them also showed consistently high SUMO2 expression [Fig. 3 E–G, cell lines are available for research; Additional file 4: Table S34] [42]. The gene discussed is SUMO2; the disease is glioblastoma.